Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells

Cancer Immunology Immunotherapy

Volumn 42, Issue 4, 1996, Pages 213-220

  Prechel, M Margaret ^a,b   Lozano, Yvonne ^a   Wright, Mark A ^a   Ihm, Joe ^a   Young, M Rita I ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

cancer; interleukin 12; natural suppressor cells; tumor; vitamin D3

Indexed keywords

COLECALCIFEROL; GAMMA INTERFERON; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; STEM CELL; SUPPRESSOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CHOLECALCIFEROL; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-12; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES;

EID: 0029899623     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050273     Document Type: Article

References (51)

1. Ploemacher RE, Soest PL van, Boudewijn A, Neben S (1993) Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or steel factor. Leukemia 9: 1374
2. Bellone G, Trinchieri G (1994) Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J Immunol 153: 930
3. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U, Stern AS (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147: 874
4. Trinchieri G, Scott P (1994) The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 15: 460
5. Brunda MJ (1994) Interleukin-12. J Leukoc Biol 55: 280
6. Bertagnolli MM, Lin B, Young D, Herrmann SH (1992) IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 149: 3378
7. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143: 127
8. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, Abbas AK (1994) Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 152: 2172
9. Alzona M, Jack H, Fisher RI, Ellis TM (1995) IL-12 activates IFN-γ production through the preferential activation of CD30 T cells. J Immunol 154: 9
10. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G (1994) Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156: 480
11. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82: 2790
12. Andrew JV, Schoof DD, Bertagnolli MM, Peoples GE, Goedegebuure PS, Eberlein TJ (1993) Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytes. Immunother 14: 1
13. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153: 1697
14. Tahara H, Zeh HJ, Storkus WJ, Pappo I, Watkins SC, Gubler U, Wolf SF, Robbins PD, Lotze MT (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 54: 182
15. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT (1995) Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155: 1393
16. Prechel MM, Lozano Y, Wright MA, Ihm J, Young MRI (1995) Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells. Cancer Lett 92: 235
17. Marshall E (1995) Cancer trial of interleukin-12 halted. Science 268: 1555
18. Hall SS (1995) IL-12 at the crossroads. Science 268: 1432
19. Alleva DG, Burger CJ, Elgert KD (1994) Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ. Scan J Immunol 39: 31
20. Walker TM, Burger CJ, Elgert KD (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cell Immunol 154: 342
21. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Budowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53: 1380
22. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK (1993) An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 151: 4847
23. Young MRI (1994) Eicosanoids and the immunology of cancer. Cancer Metastasis Rev 13: 337
24. 2. J Immunol 153: 1674
25. Inge TH, Hoover SK, Frank JL, Kawabata TT, Bethke KP, Bear HD (1992) Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide. Cancer Immunol Immunother 35: 119
26. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1: 95
27. 2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J Leukoc Biol 53: 86
28. 3 plus γ-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells. Cancer Res 53: 6006
29. Maier T, Holda JH, Claman HN (1989) Natural suppressor cells. Prog Clin Biol Res 288: 235
30. Lang SH, Miller WR, Duncan W, Habib FK (1994) Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59: 235
31. Schmidt-Wolf IG, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S (1992) T-cell subsets and suppressor cells in human bone marrow. Blood 80: 3242
32. Schreiber KL, Forman J (1993) Effects of bone marrow-derived natural suppressor activity on B cell responses to lipopolysaccharide. Transplantation 56: 700
33. + natural suppressor cells on IL-2 and IL-4 utilization in MLR. Transplantation 58: 1096
34. Brooks-Kaiser JC, Bourque LA, Hoskin DW (1993) Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide. Immunopharmacol 25: 117
35. Moore SC, Theus SA, Barnett JB, Soderberg LS (1992) Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell Immunol 141: 398
36. Young MRI, Young ME, Wright MA (1990) Stimulation of immune suppressive bone marrow cells by colony stimulating factors. Exp Hematol 18: 806
37. Moore SC, Shaw MA, Soderberg SF (1992) Transforming growth factor-β is the major mediator of natural suppressor cells derived from normal bone marrow. J Leukoc Biol 52: 596
38. + tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte-macrophage progenitor cells with low doses of interferon-γ plus tumor necrosis factor-α. Cancer Immunol Immunother 38: 9
39. Young MRI, Wright MA (1992) Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res 52: 6335
40. Schmidt-Pak A, Ip G, Wright MA, Young MRI (1995) Treating tumor-bearing mice with low dose interferon-γ plus tumor necrosis factor-α to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to IL-2 immunotherapy. Cancer Res 55: 885
41. 3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblasts. Blood 77: 1912
42. 3 diminishes tumor-induced myelopoiesis and associated immune suppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 41: 37
43. 3 prevents insulitis in NOD mice. Diabetes 41: 1491
44. Young MRI, Young ME, Wright MA (1990) Myelopoiesis-associated suppressor cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int J Cancer 46: 245
45. Young MRI, Wright MA, Coogan M, Young ME, Bagash J (1992) Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunol Immunother 35: 14
46. Yanagida T, Kato T, Igarashi O, Inoue T, Nariuchi H (1994) Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J Immunol 152: 4919
47. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178: 1223
48. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539
49. Hoskin DW, Bowser DA, Brooks-Kaiser JC (1992) Soybean agglutinin-positive natural suppressor cells in mouse bone marrow inhibit interleukin 2 production and utilization in mixed lymphocyte reactions. J Leukoc Biol 51: 649
50. Sigiura K, Ikeara S, Inaba M, Haraguchi S, Ogata H, Sardina EE, Sugawara M, Ohta Y, Good RA (1992) Enrichment of murine bone marrow natural suppressor activity in the traction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. J Exp Hematol 20: 256
51. Young MRI, Wright MA, Matthews JP, Malik I, Prechel M (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J Immunol 156: 1916